blood collection News
-
Seventh Sense Blood Collection Technology Key Part of Gateway Genomics’ SneakPeek Snap for Gender DNA Test
Making blood collection simpler, more convenient, and more comfortable. That’s our mission, and we are thrilled to share that our partner, Gateway Genomics, is leveraging our TAP II blood collection technology in its product offering, the SneakPeek Early Gender DNA Test. Called SneakPeek Snap, the blood collection device is included as part of the SneakPeek at-home blood collection kit. ...
-
Seventh Sense Biosystems Expands to European Markets for Consumer Blood Collection with TAP II CE Marking
Seventh Sense Biosystems, Inc. (7SBio), developers of the world’s first push-button blood collection device, announced today that the company has received CE mark approval from the European Commission for its TAP® II blood collection device. This clearance opens up European Union markets for consumers and patients to access simple, convenient, and more comfortable blood collection ...
-
Seventh Sense Biosystems Unveils New Name: YourBio Health; Raises $21m Funding to Help Fuel Growth
Seventh Sense Biosystems, Inc., developers of the world’s first painless push-button blood collection device, announced today its new corporate name, YourBio Health, Inc., which reflects the company’s focus on putting health information in the hands of the individual. YourBio Health enables individuals to collect a blood sample and receive the results via a secure website from the ...
-
Babson Diagnostics, BD Expand Strategic Partnership to Advance Diagnostic Blood Collection in New Care Settings
Babson Diagnostics, a science-first, health care technology company, and BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the expansion of a strategic partnership to move blood sample collection into new care settings, including enabling patients to collect blood samples at home for diagnostic testing. Since 2019, the two companies ...
-
S.F.-based startup raises $25M to expand blood collection technologies
San Francisco medical device company Velano Vascular closed a $25 million second round of financing, bringing its total overall to $50 million. The new capital will go toward expanding its needle-less blood draw device and to developing new technologies. CEO Eric Stone would not reveal what these new technologies will entail but said they will fall within the company’s mission ...
-
HumanPeople Incorporate TAP II for Home Collection of Blood Samples
Our customer HumanPeople, a UK based personalized health company, announced plans to enhance their service by integrating TAP II, following our recent CE Mark. We are thrilled to see TAP II, the blood collection product we designed, solving problems for them. Below are a few lines from their post highlighting how TAP II helped HumanPeople improve their customer experience and efficiencies. ...
-
Kurin, Inc. Announces Launch of Its Proprietary Push-button Needle System
Kurin, Inc., the inventor and manufacturer of the Kurin® blood culture collection sets announced that they have commenced the commercial launch of their push-button needle, to be used as part of Kurin blood culture sets. The Advance Safety Needle System was tested in 2021 and is now being sold into accounts using Kurin. “We are proud to commercialize the Advance Safety Needle, as there ...
By Kurin, Inc.
-
Kurin, Inc. announces UK clinical study results showing significant decrease in blood culture contaminations with the Kurin Lock™
Kurin Inc., the inventor and manufacturer of 510(k)-cleared Kurin® blood culture collection sets, announced today a new clinical study supporting the efficacy of their blood culture collection product. Authors from Guy’s and St. Thomas’ NHS Foundation Trust, a prestigious London-based hospital, presented their data at the recent Infection Prevention Society conference in ...
By Kurin, Inc.
-
Moffitt Cancer Center Advances Patient Standard of Care by Introducing Needleless Blood Draws
Moffitt Cancer Center has adopted a new needle-free method of blood collection for patients in treatment who often need to undergo repeated needle sticks in a day, becoming the first cancer center in Florida to offer this pain-free technology as part of its world-class cancer care. In its continuing efforts of being at the forefront of innovation, last year the cancer center piloted the ...
-
Velano Secures Additional Funding to Meet Commercial Demand for PIVO, Fueled by Industry Move to One-Stick Hospitalization
SAN FRANCISCO, Dec. 17, 2019 (GLOBE NEWSWIRE) — Vascular access technology pioneer Velano Vascular today announced that it has closed the second tranche of a $25 million growth financing that will fuel commercialization and the launch of additional novel inpatient medical device solutions. This new investment builds on an initial tranche closed in the first half of 2019 and brings ...
-
Safe and Simple Specimen Transport with SpeciSafe
SpeciSafe secondary packaging containers provide a safe, convenient and economical solution for compliant mailing of biohazardous and clinical specimens. They provide an easy way to meet the requirements of the UN standard UN3373 for transport of biological samples. The extensive SpeciSafe range includes solutions for screw cap microtubes, serum vials, vacuum blood collection tubes, cryovials, ...
-
Kurin, Inc. Announces Removal of Magnolia Patent Infringement Lawsuit Trial Date
Kurin Inc., the inventor and manufacturer of Kurin® blood culture collection sets, announced that the U.S. District Court in Delaware has removed the trial date from the docket in the patent-infringement lawsuit brought against Kurin by Magnolia Medical. The Court indicated that, if necessary, it will provide a trial date after it decides motions for summary judgment. This delay followed ...
By Kurin, Inc.
-
Stephen Hahn, M.D., former U.S. FDA Commissioner, joins YourBio Health as interim Chief Medical Officer
YourBio Health, Inc., developers of the world’s first painless push-button blood collection device, announced today that Stephen Hahn, M.D. joins as interim Chief Medical Officer; he also serves as the Chief Medical Officer, for the Preemptive Medicine and Health Security initiative at Flagship Pioneering at-large. Dr. Hahn previously served as the U.S. Food and Drug Administration ...
-
YourBio Health launches nearly painless, at-home COVID-19 antibody test
YourBio Health, formerly Seventh Sense Biosystems, Inc., developers of the world’s first push-button blood collection device, announced the launch of its website where UK consumers can order a convenient, easy to use, nearly painless and accurate COVID-19 antibody test. “We’re happy to launch our COVID-19 antibody test service to UK consumers today,” said Stephen Hahn, ...
-
Kurin, Inc. Named to Inc.’s Inaugural Best in Business List in the Prosperous and Thriving Category
Kurin, Inc. has been named to Inc.’s inaugural Best in Business list in the Prosperous and Thriving category. Inc. created the Best in Business Awards to honor companies that have gone above and beyond to make a positive difference. The list, which can be found in the Winter issue of Inc. (on newsstands December 29, 2020), recognizes small- and medium-size privately held American ...
By Kurin, Inc.
-
Velano’s Vascular Access Technologies Help Hospitals Meet 2021 Infusion Therapy Standards of Practice
SAN FRANCISCO, January 25, 2021 — Vascular access technology pioneer Velano Vascular today revealed that the 2021 Infusion Therapy Standards of Practice, 8th Ed., include its needle free PIVO™ device and evidence of the procedure’s improved performance for inpatient blood draws. Updated every five years and considered the preeminent guidance for infusion therapy, the newly reset ...
-
Velano Vascular Named Top Impact Company for 2021 by Real Leaders
Vascular access technology pioneer Velano Vascular was today named a Top Impact Company for 2021 by Real Leaders, the world’s first business and sustainable leadership magazine. Velano was recognized alongside such notable brands as Tesla, Beyond Meat, and Patagonia on the 2021 list for its work making hospital stays more humane and less risky for both patients and practitioners. Through ...
-
Kurin, Inc. announces results on Kurin efficacy from Oishei Children`s Hospital with zero blood culture
Kurin Inc., the inventor and manufacturer of 510(k)-cleared Kurin® blood culture collection sets, announced today that Oishei Children’s Hospital, a member of Kaleida Health, in Buffalo, NY, presented their findings on their use of Kurin at the recent Association for Professionals in Infection Control conference. This is the first study of Kurin, a passive low-volume blood culture ...
By Kurin, Inc.
-
Kurin, Inc. announces peer-reviewed publication on Kurin® efficacy from Central Texas Veterans Health Care System
Kurin Inc., the inventor and manufacturer of 510(k)-cleared Kurin® blood culture collection sets, announced today that the Central Texas VA Health Care System in Temple, TX, published their findings comparing results of two devices: Kurin and Steripath® (Magnolia Medical Technologies, Inc.) in the online edition of the Journal of Emergency Nursing. This is the first peer-reviewed ...
By Kurin, Inc.
-
Velano’s Vascular Access Technologies Help Hospitals Meet 2021 Infusion Therapy Standards of Practice
Vascular access technology pioneer Velano Vascular today revealed that the 2021 Infusion Therapy Standards of Practice, 8th Ed., include its needle free PIVO™ device and evidence of the procedure’s improved performance for inpatient blood draws. Updated every five years and considered the preeminent guidance for infusion therapy, the newly reset standards from the Infusion Nurses ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you